Later on, a revised strategy for the delivery of doxorubicin into glioma was utilized, involving the conjugation of the γ-carboxyl group of glutamate to the surface of liposomes and PLGA nanoparticles, leaving the α-amino and α-carboxyl groups free for recognition by LAT1. Here, SLC7A5 is linked to glioma.